Pacific Biosciences of California Investor Relations Material
Latest events
Q3 2024
Pacific Biosciences of California
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Pacific Biosciences of California Inc
Access all reports
Segment Data
Access more data
Revenue by
Products and services
Consumable
Instrument
Service and other
Expenses by
Financials
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT™) Sequencing platform enables single molecule real-time detection of biological processes. Its SMRT Sequencing technology provides various applications, including de novo sequencing to assemble a genome from scratch; targeted sequencing to sample specific regions of interest; and epigenetic sequencing to study how environmental factors affect gene expression. It has collaboration with Cold Spring Harbor Laboratory to expand its efforts in developing third-generation DNA sequencing technology.
Key slides for Pacific Biosciences of California Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Pacific Biosciences of California Inc
Q3 2024
Pacific Biosciences of California Inc
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
PACB
Country
🇺🇸 United States